Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.

View/Open
Volume
101
Pagination
e339 - e342
DOI
10.3324/haematol.2015.139667
Journal
Haematologica
Issue
8
Metadata
Show full item record
Authors
de Haart, SJ; Holthof, L; Noort, WA; Minnema, MC; Emmelot, ME; Aarts-Riemens, T; Doshi, P; Sasser, K; Yuan, H; de Bruijn, J
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12345
Collections
Language
eng
Copyright statements
© 2016, Ferrata Storti Foundation